IT8567165A1 - Composizioni a base di liposomi, particolarmente per mantenere ed immobilizzare una riserva di agenti biologicamente attivi, e relativo procedimento d'impiego. - Google Patents

Composizioni a base di liposomi, particolarmente per mantenere ed immobilizzare una riserva di agenti biologicamente attivi, e relativo procedimento d'impiego.

Info

Publication number
IT8567165A1
IT8567165A1 IT1985A67165A IT6716585A IT8567165A1 IT 8567165 A1 IT8567165 A1 IT 8567165A1 IT 1985A67165 A IT1985A67165 A IT 1985A67165A IT 6716585 A IT6716585 A IT 6716585A IT 8567165 A1 IT8567165 A1 IT 8567165A1
Authority
IT
Italy
Prior art keywords
immobilizing
liposomes
reserve
maintaining
biologically active
Prior art date
Application number
IT1985A67165A
Other languages
English (en)
Other versions
IT1184887B (it
IT8567165A0 (it
Original Assignee
The Liposome Company Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Liposome Company Inc filed Critical The Liposome Company Inc
Publication of IT8567165A0 publication Critical patent/IT8567165A0/it
Publication of IT8567165A1 publication Critical patent/IT8567165A1/it
Application granted granted Critical
Publication of IT1184887B publication Critical patent/IT1184887B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
IT67165/85A 1984-02-15 1985-02-15 Composizione a base di liposomi particolarmente per mantenere ed immobilizzare una riserva di agenti biologicamente attivi e relativo procedimento d impiego IT1184887B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58021284A 1984-02-15 1984-02-15
US06/695,887 US4708861A (en) 1984-02-15 1985-01-31 Liposome-gel compositions

Publications (3)

Publication Number Publication Date
IT8567165A0 IT8567165A0 (it) 1985-02-15
IT8567165A1 true IT8567165A1 (it) 1986-08-15
IT1184887B IT1184887B (it) 1987-10-28

Family

ID=27077978

Family Applications (1)

Application Number Title Priority Date Filing Date
IT67165/85A IT1184887B (it) 1984-02-15 1985-02-15 Composizione a base di liposomi particolarmente per mantenere ed immobilizzare una riserva di agenti biologicamente attivi e relativo procedimento d impiego

Country Status (10)

Country Link
US (1) US4708861A (it)
EP (1) EP0172907B1 (it)
CA (1) CA1245156A (it)
DE (1) DE3583779D1 (it)
DK (1) DK468685A (it)
IE (1) IE58975B1 (it)
IL (1) IL74343A0 (it)
IT (1) IT1184887B (it)
SG (1) SG18692G (it)
WO (1) WO1985003640A1 (it)

Families Citing this family (181)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60231609A (ja) * 1984-04-28 1985-11-18 Terumo Corp リポソ−ム製剤
IL75315A (en) * 1984-05-25 1991-07-18 Vestar Inc Method for stabilization of vesicles
US5008109A (en) * 1984-05-25 1991-04-16 Vestar, Inc. Vesicle stabilization
US4761288A (en) * 1984-09-24 1988-08-02 Mezei Associates Limited Multiphase liposomal drug delivery system
US4897269A (en) * 1984-09-24 1990-01-30 Mezei Associates Limited Administration of drugs with multiphase liposomal delivery system
DE3576117D1 (de) * 1984-09-24 1990-04-05 Michael Mezei Mehrphasige pharmazeutische zusammensetzung.
JPH0611709B2 (ja) * 1984-10-19 1994-02-16 チロン コーポレイション 角膜基質創傷の治療のための組成物
US4900556A (en) * 1985-04-26 1990-02-13 Massachusetts Institute Of Technology System for delayed and pulsed release of biologically active substances
EP0199362A3 (en) * 1985-04-26 1987-10-07 Massachusetts Institute Of Technology System and apparatus for delayed and pulsed release of biologically active substances
US4921757A (en) * 1985-04-26 1990-05-01 Massachusetts Institute Of Technology System for delayed and pulsed release of biologically active substances
US4873075A (en) * 1985-09-10 1989-10-10 The University Of Michigan Polyiodinated triglyceride analogs as radiologic agents
US4957729A (en) * 1985-09-10 1990-09-18 The University Of Michigan Polyiodinated triglyceride analogs as radiologic agents
GB8522963D0 (en) * 1985-09-17 1985-10-23 Biocompatibles Ltd Microcapsules
FR2597345B1 (fr) * 1986-04-22 1990-08-03 Oreal Composition cosmetique ou pharmaceutique a base d'une dispersion aqueuse de spherules lipidiques.
US4877619A (en) * 1986-08-25 1989-10-31 Vestar, Inc. Liposomal vesicles for intraperitoneal administration of therapeutic agents
ES2068197T3 (es) * 1987-01-27 1995-04-16 Vestar Inc Vehiculo de liberacion a base de fosfolipidos para ingredientes activos insolubles en agua.
US4839111A (en) * 1987-02-02 1989-06-13 The University Of Tennessee Research Corporation Preparation of solid core liposomes
US5023086A (en) * 1987-03-13 1991-06-11 Micro-Pak, Inc. Encapsulated ionophore growth factors
FR2616659A1 (fr) * 1987-06-16 1988-12-23 Sederma Sa Procede pour favoriser la penetration de macromolecules a travers l'epiderme utilise pour la realisation de preparations cosmetiques
EP0391909B1 (en) * 1987-09-03 1994-08-17 The University Of Georgia Research Foundation, Inc. Ocular cyclosporin composition
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
EP0390849B1 (en) * 1987-12-03 1993-01-07 The Liposome Company, Inc. Methyl cellulose pharmaceutical composition
US4898734A (en) * 1988-02-29 1990-02-06 Massachusetts Institute Of Technology Polymer composite for controlled release or membrane formation
MX9203504A (es) * 1988-04-20 1992-07-01 Liposome Co Inc Complejo agente: lipido activo de alta proporcion.
WO1989011272A1 (en) * 1988-05-20 1989-11-30 The Liposome Company, Inc. High ratio active agent:lipid complex
US5269979A (en) * 1988-06-08 1993-12-14 Fountain Pharmaceuticals, Inc. Method for making solvent dilution microcarriers
US5133965A (en) * 1988-06-08 1992-07-28 Fountain Pharmaceuticals, Inc. Dressing material having adsorbed thereon a solvent dilution microcarrier precursor solution
US4937078A (en) * 1988-08-26 1990-06-26 Mezei Associates Limited Liposomal local anesthetic and analgesic products
BE1001869A3 (fr) * 1988-10-12 1990-04-03 Franz Legros Procede d'encapsulation liposomiale d'antibiotiques aminoglucosidiques, en particulier de la gentamycine.
WO1990004412A1 (en) * 1988-10-27 1990-05-03 Regents Of The University Of Minnesota Liposome immunoadjuvants containing il-2
FR2638639A1 (fr) * 1988-11-08 1990-05-11 Parincos Parfumerie Cosmet Int Composition et procede d'obtention de liposomes oligolamellaires en vue d'une application en cosmetologie et dermatologie topique
US5122367A (en) * 1989-03-31 1992-06-16 Massachusetts Institute Of Technology Polyanhydride bioerodible controlled release implants for administration of stabilized growth hormone
JPH04505319A (ja) * 1989-04-04 1992-09-17 アルコン　ラボラトリーズ　インコーポレイテッド 創傷、切傷および擦傷に対する治療剤のデリバリーとしてのリポソームの使用
AU5666090A (en) * 1989-05-25 1990-12-18 Technology Unlimited Incorporated Insect repellant
US5104661A (en) * 1989-08-14 1992-04-14 Technology Unlimited, Inc. Reverse loading of liposomes
JP2785981B2 (ja) * 1989-11-20 1998-08-13 株式会社資生堂 乳化組成物
US5741513A (en) * 1990-02-08 1998-04-21 A. Natterman & Cie. Gmbh Alcoholic aqueous gel-like phospholipid composition, its use and topical preparations containing it
EP0550463B1 (en) * 1990-09-06 1996-06-26 S.C. Johnson & Son, Inc. Stabilized liposome process and compositions containing them
SE9003706L (sv) * 1990-11-21 1992-05-22 Eva Greijer Metoder foer immobilisering av liposomer i gelkulor, och gelkulor med liposomer vilka immobiliserats med anvaendning av dessa metoder
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US7196054B1 (en) * 1990-11-27 2007-03-27 The American National Red Cross Methods for treating wound tissue and forming a supplemented fibrin matrix
US6117425A (en) * 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
JP2594486B2 (ja) * 1991-01-15 1997-03-26 アルコン ラボラトリーズ インコーポレイテッド 局所的眼薬組成物
ATE132367T1 (de) * 1991-02-14 1996-01-15 Baxter Int Bindung substratspezifischer affinitätssubstanzen an liposomen
US5603872A (en) * 1991-02-14 1997-02-18 Baxter International Inc. Method of binding recognizing substances to liposomes
WO1993004672A1 (en) * 1991-09-11 1993-03-18 Pitman-Moore, Inc. Method for enhancing the immune system in a host employing liposome-encapsulated polypeptides
DE4132677C2 (de) * 1991-10-01 1995-08-24 Braun Melsungen Ag Flüchtige Inhalationsnarkotika enthaltende Liposomen, ihre Herstellung und Verwendung
US5545423A (en) * 1991-11-25 1996-08-13 Vivorx, Inc. Cytoprotective, biocompatible, retrievable macrocapsule containment systems for biologically active materials
AU3423493A (en) * 1991-12-31 1993-07-28 Zymogenetics Inc. Methods and compositions for reducing blood loss
US5665381A (en) * 1992-02-25 1997-09-09 Nexstar Pharmaceuticals, Inc. Inhibition of aggregation of drug containing particles
FR2701396B1 (fr) * 1993-02-12 1995-04-21 Oreal Procédé de stabilisation de vésicules de lipide(s) amphiphile(s) et composition pour application topique contenant lesdites vésicules stabilisées.
US5437867A (en) * 1993-03-19 1995-08-01 Collaborative Laboratories Solubilizing, thickening and emulsifying cosmetic composition and process for preparation of same
DE69328545T2 (de) * 1993-03-24 2001-07-05 Collaborative Lab Inc Kosmetisches Verabreichungssystem für Salizylsäure und Verfahren zur Herstellung desselben
CN1074923C (zh) * 1993-11-19 2001-11-21 詹森药业有限公司 微囊密封的3-哌啶基取代的1,2-苯并异唑类和1,2-苯并异噻唑类
EP0748215B1 (en) * 1994-02-17 2003-05-28 New York Blood Center, Inc. Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
FR2718369B1 (fr) * 1994-04-12 1996-06-21 Lipogel Sarl Microsphères gélifiées, leur procédé de préparation et leurs applications.
US6455304B1 (en) * 1994-07-01 2002-09-24 The Board Of Regents Of The University Of Oklahoma Hyaluronate synthase gene and uses thereof
US6951743B2 (en) 1997-10-31 2005-10-04 University Of Oklahoma Board Of Regents Hyaluronan synthase genes and expression thereof in bacillus hosts
US7091008B1 (en) * 1994-07-01 2006-08-15 The Board Of Regents Of The University Of Oklahoma Hyaluronan synthase genes and expression thereof in Bacillus hosts
EP0785774B1 (en) * 1994-10-12 2001-01-31 Focal, Inc. Targeted delivery via biodegradable polymers
US6911216B1 (en) 1994-10-12 2005-06-28 Genzyme Corporation Targeted delivery via biodegradable polymers
IT1270678B (it) * 1994-10-20 1997-05-07 Bayer Ag Liposomi al chetoprofen
GB9500116D0 (en) * 1995-01-05 1995-03-01 Ciba Geigy Ag Pharmaceutical compositions
AT408067B (de) * 1995-03-17 2001-08-27 Gebro Pharma Gmbh Pharmazeutische zusammensetzung zur topischen applizierung und verfahren zu ihrer herstellung
US6071535A (en) * 1996-01-31 2000-06-06 Collaborative Laboratories, Inc. Lipid vesicles formed with alkylammonium fatty acid salts
US5874105A (en) * 1996-01-31 1999-02-23 Collaborative Laboratories, Inc. Lipid vesicles formed with alkylammonium fatty acid salts
US6183774B1 (en) 1996-01-31 2001-02-06 Collaborative Laboratories, Inc. Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
IT1283911B1 (it) * 1996-02-05 1998-05-07 Farmigea Spa Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
US6143287A (en) * 1996-02-27 2000-11-07 New York Blood Center, Inc. Method and composition for hair removal
US6015576A (en) * 1997-08-29 2000-01-18 Bio-Sphere Technology, Inc. Method for inducing a systemic immune response to an antigen
US6117449A (en) * 1996-03-22 2000-09-12 Bio-Sphere Technology, Inc. Method for inducing a systemic immune response to a hepatitis antigen
US6207185B1 (en) 1996-03-22 2001-03-27 Bio-Sphere Technology Method for inducing a systemic immune response to an HIV antigen
US5834016A (en) * 1996-04-04 1998-11-10 Cilag Ag Liposome-based topical vitamin D formulation
US6214375B1 (en) 1996-07-16 2001-04-10 Generex Pharmaceuticals, Inc. Phospholipid formulations
WO1998011877A1 (en) * 1996-09-18 1998-03-26 Dragoco, Inc. Liposome encapsulated active agent dry powder composition
US6045823A (en) * 1996-09-19 2000-04-04 Dragoco Gerberding & Co. Ag Process for producing solid anhydrous composition, and pharmaceutical and cosmetic products comprising same
WO1998013024A2 (en) 1996-09-27 1998-04-02 Hyal Pharmaceutical Corporation Hyaluronic drug delivery system
EP0959873B1 (en) * 1996-12-20 2006-03-01 ALZA Corporation Gel composition and methods
US5935572A (en) * 1997-01-10 1999-08-10 Collaborative Laboratories, Inc. Composition containing protease separate from glycosidase for removing nits in treating lice infestation
CN101113436B (zh) * 1997-10-31 2013-02-06 俄克拉何马大学董事会 透明质酸合酶基因及其应用
EP1025211B1 (en) * 1997-10-31 2004-12-15 The Board of Regents of The University of Oklahoma Hyaluronan synthase gene and uses thereof
US7223571B2 (en) * 1998-04-02 2007-05-29 The Board Of Regents Of The Universtiy Of Oklahoma Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
US6987023B2 (en) * 1998-04-02 2006-01-17 The Board Of Regents Of The University Of Oklahoma DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use
US20080108110A1 (en) * 1998-04-02 2008-05-08 Deangelis Paul L Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
US20060188966A1 (en) * 1998-04-02 2006-08-24 Deangelis Paul L Natural, chimeric and hybrid glycosaminoglycan polymers and methods of making and using same
US6174524B1 (en) 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
US6410041B1 (en) * 1998-04-28 2002-06-25 Trustees Of Tufts College Culturing cells in presence of amphipathic weak bases and/or cations and multiple drug resistance inhibitor containing reserpine
US6290987B1 (en) 1998-09-27 2001-09-18 Generex Pharmaceuticals, Inc. Mixed liposome pharmaceutical formulation with amphiphiles and phospholipids
US7094581B2 (en) * 1998-10-26 2006-08-22 The Board Of Regents Of The University Of Oklahoma Hyaluronan synthases and methods of making and using same
US6271200B1 (en) 1998-12-21 2001-08-07 Generex Pharmaceuticals Inc. Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles
US6613352B2 (en) 1999-04-13 2003-09-02 Universite De Montreal Low-rigidity liposomal formulation
US6521431B1 (en) 1999-06-22 2003-02-18 Access Pharmaceuticals, Inc. Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments
GB9919131D0 (en) * 1999-08-14 1999-10-13 Depuy Int Ltd Joint lubrication
US6375968B1 (en) 1999-10-22 2002-04-23 3M Innovative Properties Company Encapsulated active material immobilized in hydrogel microbeads
AU8008300A (en) 1999-11-01 2001-05-14 Alcon Inc. Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum
DE60141567D1 (de) 2000-01-25 2010-04-29 Edwards Lifesciences Corp Freisetzungssysteme zur behandlung von restenose und anastomotischer intimaler hyperplasie
AU2001245513A1 (en) * 2000-03-06 2001-09-17 Kumarpal A. Shah Method for immune switching
US20030211974A1 (en) * 2000-03-21 2003-11-13 Brodbeck Kevin J. Gel composition and methods
US20050287638A1 (en) * 2000-04-25 2005-12-29 Weigel Paul H Hyaluronan receptor for endocytosis, variants thereof, and methods of making and using same
US6436406B1 (en) 2000-06-15 2002-08-20 A. Glenn Braswell Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis
PT1305033E (pt) 2000-07-28 2005-01-31 Alcon Inc Composicoes farmaceuticas que contem tobramicina e goma de xantano
US6648911B1 (en) 2000-11-20 2003-11-18 Avantec Vascular Corporation Method and device for the treatment of vulnerable tissue site
US20050013810A1 (en) * 2001-05-08 2005-01-20 Waller Edmund K Regulating immune response using dendritic cells
US7544670B2 (en) 2001-06-14 2009-06-09 The Regents Of The University Of California HoxD3, HoxA3 and HoxB3 compositions and methods for improved wound healing
AU2002312514A1 (en) * 2001-06-14 2003-01-02 Regents Of The University Of California Hoxd3 compositions ad methods for improved wound healing
AU2002323151A1 (en) * 2001-08-13 2003-03-03 University Of Pittsburgh Application of lipid vehicles and use for drug delivery
US20100104631A1 (en) * 2001-08-13 2010-04-29 Lipella Pharmaceuticals Inc. Method of treatment for bladder dysfunction
US8110217B2 (en) * 2001-08-13 2012-02-07 University Of Pittsburgh Sphingomyelin liposomes for the treatment of hyperactive bladder disorders
NZ533436A (en) 2001-11-14 2007-10-26 Alza Corp Catheter injectable depot compositons and uses thereof
WO2003041685A1 (en) * 2001-11-14 2003-05-22 Alza Corporation Injectable depot composition
US20070020737A1 (en) * 2001-12-03 2007-01-25 Pummill Philip E Hyaluronan synthases and methods of making and using same
US20040018237A1 (en) * 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
KR20050038008A (ko) 2002-07-31 2005-04-25 알자 코포레이션 주사용 저장형 조성물 및 이의 용도
DK1539101T3 (da) 2002-07-31 2009-04-27 Alza Corp Injicerbare, multi-modale polymere depotsammens tninger og anvendelser deraf
US6866856B2 (en) * 2002-12-31 2005-03-15 Avon Products, Inc. Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis
WO2004103333A1 (de) * 2003-05-24 2004-12-02 Juvena (International) Ag Gewebekulturmedien als bestandteil von kosmetika
US20050129751A1 (en) * 2003-12-16 2005-06-16 Rothenberg Barry E. Drug delivery compositions and methods
WO2006029074A2 (en) * 2004-09-03 2006-03-16 Piedmont Pharmaceuticals, Llc Methods for transmembrane treatment and prevention of otitis media
DE102005037844A1 (de) * 2005-08-04 2007-04-05 Intendis Gmbh Wasserfreies Mehr-Phasen-Gel-System
US20070154546A1 (en) * 2005-12-30 2007-07-05 Zhang Jack Y Sustained release pharmaceutical compositions
US8123744B2 (en) * 2006-08-29 2012-02-28 Covidien Ag Wound mediating device
AU2007351891A1 (en) 2006-10-03 2008-10-30 The Board Of Regents Of The University Of Oklahoma Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
EP2114349B1 (en) 2006-12-28 2016-09-14 3M Innovative Properties Company Dental filler and methods
US20080214460A1 (en) * 2007-01-18 2008-09-04 Ceramoptec Industries, Inc. Formulations for cosmetic and wound care treatments with photosensitizers as fluorescent markers
US20090162423A1 (en) * 2007-12-20 2009-06-25 Ceramoptec Industries, Inc. Formulations for cosmetic and wound care treatments with photosensitizes as fluorescent markers
EP2155165A1 (en) * 2007-04-20 2010-02-24 BioCure, Inc. Drug delivery vehicle containing vesicles in a hydrogel base
US20100080773A1 (en) 2008-09-26 2010-04-01 Sdg, Inc. Orally Bioavailable Lipid-Based Constructs
US8962015B2 (en) 2007-09-28 2015-02-24 Sdg, Inc. Orally bioavailable lipid-based constructs
WO2009062299A1 (en) * 2007-11-15 2009-05-22 Lipodur Pharmaceutical Inc. Gel-stabilized liposome compositions, methods for their preparation and uses thereof
CN102149398B (zh) * 2008-09-11 2013-12-04 I·B·R·以色列生物科技研究有限公司 雪片莲属鳞茎提取物及其用途
WO2010057007A1 (en) * 2008-11-14 2010-05-20 Archer Daniels Midland Company Organogel compositions and processes for producing
US20100166739A1 (en) * 2008-12-30 2010-07-01 Lipella Paharmaceuticals Inc. Methods and Compositions for Diagnosing Urological Disorders
EP2601934A1 (en) * 2009-01-22 2013-06-12 Ludwig-Maximilians-Universität München Vesicular phospholipid gels comprising proteinaceous substances
WO2011075623A1 (en) * 2009-12-18 2011-06-23 Latitude Pharmaceuticals, Inc. One - phase gel compos ition compri s ing phos pholi pids
MX339957B (es) * 2010-05-14 2016-06-20 Archer Daniels Midland Co Composiciones alimenticias que comprenden organogeles.
WO2012050896A2 (en) * 2010-09-29 2012-04-19 Kansas State University Research Foundation Protease selective supramolecular assemblies
WO2012070971A1 (ru) * 2010-11-22 2012-05-31 Farber Boris Slavinovich Косметологическая и фармацевтическая композиция для омоложения и восстанов- ления кожи, в том числе после хирургических операций
CN103547258B (zh) 2011-03-17 2017-10-20 特兰斯德梅尔生物工艺股份有限公司 局部一氧化氮系统及其使用方法
US8808734B2 (en) * 2011-07-11 2014-08-19 Full Spectrum Laboratories Limited Cannabinoid formulations
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US20160303242A1 (en) 2013-12-09 2016-10-20 Durect Corporation Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
EP3154520B1 (en) * 2014-06-13 2020-04-29 HEIDELTEC GmbH Matrix stabilized liposomes
KR101509424B1 (ko) 2014-12-02 2015-04-10 주식회사 뉴앤뉴 주름 개선용 복합 조성물 및 이를 포함하는 주름 개선용 화장품
SG11201908052PA (en) 2017-03-13 2019-09-27 Sdg Inc Lipid-based nanoparticles with enhanced stability
US11077173B2 (en) 2017-03-13 2021-08-03 Sdg, Inc. Lipid-based nanoparticles and methods using same
TWI763991B (zh) * 2019-05-02 2022-05-11 行政院原子能委員會核能研究所 新式眼用凝膠及其製備方法
CN110658272A (zh) * 2019-09-23 2020-01-07 佛山科学技术学院 一种复合多糖脂质体包封率的检测方法
CA3167217A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
NL2035417A (en) 2022-07-19 2024-01-26 Coty Inc Cosmetic composition

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL262194A (it) * 1960-03-10 1900-01-01
US3937668A (en) * 1970-07-15 1976-02-10 Ilse Zolle Method for incorporating substances into protein microspheres
JPS5814253B2 (ja) * 1974-04-10 1983-03-18 カンザキセイシ カブシキガイシヤ ビシヨウカプセルノ セイゾウホウホウ
US4377567A (en) * 1978-10-02 1983-03-22 The Procter & Gamble Company Lipid membrane drug delivery
US4310506A (en) * 1979-02-22 1982-01-12 California Institute Of Technology Means of preparation and applications of liposomes containing high concentrations of entrapped ionic species
US4310505A (en) * 1979-11-08 1982-01-12 California Institute Of Technology Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances
HU184141B (en) * 1979-12-27 1984-07-30 Human Oltoanyagtermelo Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof
US4431428A (en) * 1981-09-30 1984-02-14 Trimedyne, Inc. Bio-artificial organ using microencapsulated enzymes
US4439488A (en) * 1982-02-26 1984-03-27 The United States Of America As Represented By The Secretary Of Agriculture Encapsulation by entrapment within polyhydroxy polymer borates
US4434153A (en) * 1982-03-22 1984-02-28 Alza Corporation Drug delivery system comprising a reservoir containing a plurality of tiny pills
US4460560A (en) * 1982-06-18 1984-07-17 University Of Southern California Drug delivery by polymeric carriers
US4413069A (en) * 1982-09-20 1983-11-01 Marshall Joseph W Composition with selectively active modifier and method
FR2548902B1 (fr) * 1983-07-13 1986-04-11 Guerbet Sa Gel pour embolisation therapeutique
IL75315A (en) * 1984-05-25 1991-07-18 Vestar Inc Method for stabilization of vesicles

Also Published As

Publication number Publication date
EP0172907A1 (en) 1986-03-05
EP0172907A4 (en) 1986-07-23
WO1985003640A1 (en) 1985-08-29
IT1184887B (it) 1987-10-28
DK468685D0 (da) 1985-10-14
DK468685A (da) 1985-10-14
IL74343A0 (en) 1985-05-31
DE3583779D1 (de) 1991-09-19
IE58975B1 (en) 1993-12-15
SG18692G (en) 1992-04-16
CA1245156A (en) 1988-11-22
IT8567165A0 (it) 1985-02-15
US4708861A (en) 1987-11-24
EP0172907B1 (en) 1991-08-14
IE850359L (en) 1985-08-15

Similar Documents

Publication Publication Date Title
IT8567165A1 (it) Composizioni a base di liposomi, particolarmente per mantenere ed immobilizzare una riserva di agenti biologicamente attivi, e relativo procedimento d'impiego.
FR2598148B1 (fr) Formulations a base d'amidon.
PT90099A (pt) Processp aara a preparacao de 2',3'-di-dehidronucleosidos
IT8620117A0 (it) Polidesossiribonucleotidi procedimento per l'ottenimento di chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante.
IT1206452B (it) Ammidine ad attivita' farmaceutica e relativo procedimento di fabbricazione.
IT8721063A0 (it) Composizione ad attivita'tricogena.
IT8520085A0 (it) Tenuta per stato di inattivita'.
ZA853687B (en) Biologically active agents containing substituted isoxazolidines,a new isoxazolidines and their preparation
FR2673037B1 (fr) Cathode de reserve pour emission d'eletrons.
IT8449172A1 (it) Composizione farmaceutica ad attivita' vasodilatatrice e ipotensiva a base di nifedipina
IT8721990A0 (it) Composizione ad uso topico avente attivita' tricogena, antiforfora ed antiseborroica.
OA08067A (fr) Application thérapeutique d'aminométhylènes-2 indanediones-1,3 substituées sur l'azote.
IT8622780A0 (it) "2-cloro-12-(-3-dimetilammino-2-metilpropil)-12h-dibenzo-/d,g//1,3,6/d iossazocine otticamente attive eprocedimento per la loro preparazione.
IT8619288A0 (it) Formulazioni farmaceutiche iniettabili di principi attivi adattivita' anestetica generale.
IT1229178B (it) Procedimento per l'ottenimento di una miscela di ribonucleotidi.
JPS6416755A (en) Manufacture of n-(3',4'-dimethoxycinnamoyl)-aniline derivative
FR2583416B1 (fr) Composition d'aminobenzylamines.
IT8520514A0 (it) Composizioni di farmaci dotate di attivita' antimicrobica eprocedimento per la loro preparazione.
EP0297117A4 (en) BIOLOGICALLY ACTIVE AGENT.
IT8520602V0 (it) Struttura di perno sagomato, utilizzabile per l'ancoraggio di protesi dentarie fisse.
DE3567656D1 (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions containing them
IT8419929A0 (it) Nuovi procedimenti per lapreparazione di composto conattivita' antiulcera.
FR2605225B1 (fr) Compositions pharmaceutiques a base d'urokinase
IT8720494A0 (it) 2,3-diidro-1,4 -benzodiossin2,2-disostituiti ad attivita'ipotensiva
IT8421961V0 (it) Supporto per la confezione e l'esposizione di calendari.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19940225